| |
 |
|
Class Information
Number: 514/34
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Carbohydrate (i.e., saccharide radical containing) doai > O-glycoside > Oxygen of the saccharide radical bonded directly to a polycyclo ring system of three or more carbocyclic rings > Oxygen of the saccharide radical bonded directly to a polycyclo ring system of four carbocyclic rings (e.g., daunomycin, etc.)
Description: Subject matter wherein the oxygen of the saccharide radical is directly bonded to a polycyclo ring system of exactly four carbocyclic rings.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6372719 |
.alpha..nu..beta.3 integrin antagonists in combination with chemotherapeutic agents |
Apr. 16, 2002 |
| 6369037 |
Controlled release of doxorubicin |
Apr. 9, 2002 |
| 6338859 |
Polymeric micelle compositions |
Jan. 15, 2002 |
| 6310039 |
Antineoplastic conjugates of transferrin, albumin and polyethylene glycol |
Oct. 30, 2001 |
| 6303569 |
Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
Oct. 16, 2001 |
| 6290929 |
Cancer treatment |
Sep. 18, 2001 |
| 6284738 |
Injectable ready-to-use solutions containing an antitumor anthracycline glycoside |
Sep. 4, 2001 |
| 6284747 |
Pharmaceutical formulation |
Sep. 4, 2001 |
| 6284737 |
Methods of treatment with anthracycline derivatives |
Sep. 4, 2001 |
| 6277836 |
Methods and compositions for treating inflammatory bowel disease |
Aug. 21, 2001 |
| 6274561 |
Antitumor agents comprising as the principal compounds containing silicon and nitrogen |
Aug. 14, 2001 |
| 6265385 |
Topoisomerase II poison and bis-dioxopiperazine derivative combination therapy |
Jul. 24, 2001 |
| 6258786 |
13-dihydro-3' aziridino anthracyclines |
Jul. 10, 2001 |
| 6232294 |
Neuro-function regulatory agent |
May. 15, 2001 |
| 6218374 |
Pharmaceutical formulation |
Apr. 17, 2001 |
| 6218369 |
Pharmaceutical compositions containing flavanolignanes and methods for using same as an antiproliferative |
Apr. 17, 2001 |
| 6214863 |
Antitumor compositions containing taxane derivatives |
Apr. 10, 2001 |
| 6214388 |
Immunoliposomes that optimize internalization into target cells |
Apr. 10, 2001 |
| 6191119 |
Combination therapy including 9-nitro-20(S)-camptothecin |
Feb. 20, 2001 |
| 6187758 |
Anthracycline glycosides |
Feb. 13, 2001 |
| 6180095 |
Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
Jan. 30, 2001 |
| 6177404 |
Conjugates useful in the treatment of benign prostatic hyperplasia |
Jan. 23, 2001 |
| 6149913 |
Compositions and methods for controlling insects |
Nov. 21, 2000 |
| 6147094 |
Reduction of cardiotoxicity of an antitumor agent using manganese compound |
Nov. 14, 2000 |
| 6147060 |
Treatment of carcinomas using squalamine in combination with other anti-cancer agents |
Nov. 14, 2000 |
| 6130248 |
Tricarboxylic acid-containing oxyalkyl esters and uses thereof |
Oct. 10, 2000 |
| 6124311 |
Methods for treating resistant tumors |
Sep. 26, 2000 |
| 6121245 |
Method of treating cancer using alkylglycerols in conjunction with chemotherapy |
Sep. 19, 2000 |
| 6121244 |
Antitumoral method by administration of partricin derivatives |
Sep. 19, 2000 |
| 6107285 |
Injectable ready-to-use solutions containing an antitumor anthracycline glycoside |
Aug. 22, 2000 |
| 6103700 |
Fluoro labelled anthracyclinone and anthracycline derivatives |
Aug. 15, 2000 |
| 6087340 |
Injectable ready-to-use solutions containing an antitumor anthracycline glycoside |
Jul. 11, 2000 |
| 6080396 |
Anthracycline compound derivative and pharmaceutical preparation containing the same |
Jun. 27, 2000 |
| 6054437 |
Method for inducing death of neoplastic cells using piperazine derivatives |
Apr. 25, 2000 |
| 6048845 |
Pharmaceutical formulation |
Apr. 11, 2000 |
| 6022545 |
Usage of pathogen-killing foams |
Feb. 8, 2000 |
| 6020316 |
Glutaraldehyde modified chemotherapeutic agents and methods of use thereof |
Feb. 1, 2000 |
| 6020315 |
Preparation having increased in vivo tolerability |
Feb. 1, 2000 |
| 5977082 |
Injectable ready-to-use solutions containing an antitumor anthracycline glycoside |
Nov. 2, 1999 |
| 5965407 |
Anthracycline compound 0624 |
Oct. 12, 1999 |
| 5962216 |
Tumor-activated prodrug compounds and treatment |
Oct. 5, 1999 |
| 5958889 |
Anthracycline derivatives having 4-amino-2,4,6-trideoxy-2-fluoro-mannopyranosyl group |
Sep. 28, 1999 |
| 5955100 |
Prodrugs their preparation and use as pharmaceuticals |
Sep. 21, 1999 |
| 5948750 |
Conjugates useful in the treatment of prostate cancer |
Sep. 7, 1999 |
| 5948815 |
Methods for inhibiting bacterial cytotoxicity |
Sep. 7, 1999 |
| 5932609 |
Pharmaceutical composition for inhibiting the growth of cancers |
Aug. 3, 1999 |
| 5929104 |
Method for inducing apoptosis of cancer cell |
Jul. 27, 1999 |
| 5925669 |
Carrier compositions for anti-neoplastic drugs |
Jul. 20, 1999 |
| 5910485 |
Antitumor agents comprising as the principal compounds containing silicon and nitrogen |
Jun. 8, 1999 |
| 5908835 |
Anti-tumor compositions containing taxane derivatives |
Jun. 1, 1999 |
|
|
|
